Fortis Pharma Consulting Limited
Registered name: FORTIS PHARMA CONSULTING LIMITED
Part of Sovereign Capital Partners LLP groupFortis Pharma Consulting Limited made £3.2m revenue and £1.7m profit in the year to 30 Sep 2025.
Fortis Pharma Consulting Limited’s revenue fell 5% to £3.2m in the year to 30 Sep 2025, with £1.7m profit and 18 employees. The company is classified under “other professional, scientific and technical activities” and is based in Macclesfield; we hold 4 years of its filed accounts.
- Status
- Active
- Location
- Macclesfield, North West
- Age
- 21 yrs · since 2005
- Type
- Private Limited Company
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 30 Sep 2022 | 30 Sep 2023 | 30 Sep 2024 | 30 Sep 2025 |
|---|---|---|---|---|
| Disclosure | Full P&L | Full P&L | Full P&L | Full P&L |
| Profit & loss | ||||
| Revenue (turnover) | £4.2m | £4.3m | £3.4m | £3.2m |
| Cost of sales | £1.6m | £1.9m | £1.6m | −£1.3m |
| Gross profit | £2.6m | £2.4m | £1.8m | £1.9m |
| Operating profit | £2m | £2.1m | £1.8m | £1.8m |
| Profit before tax | £2m | £2.1m | £1.8m | £1.8m |
| Profit after tax | £2.2m | £2.1m | £1.7m | £1.7m |
| Profit (best available) | £2.2m | £2.1m | £1.7m | £1.7m |
| Staff costs | £1.1m | £1.4m | £1.2m | — |
| Employees (average) | 18 | 0 | 21 | 18 |
| Ratios | ||||
| Profit margin | 50.9% | 49.4% | 50.6% | 53.4% |
| Gross margin | 62.4% | 55% | 52.8% | 58.8% |
| Revenue per employee | £236k | — | £162k | £180k |
| Profit per employee | £120k | — | £82.1k | £96k |
| Growth (year on year) | ||||
| Revenue growth | — | ▲1.2% | ▼20.6% | ▼5.1% |
| Profit growth | — | ▼1.8% | ▼18.8% | ▲0.3% |
| Headcount growth | — | ▼100% | — | ▼14.3% |
| Balance sheet — indirect signals, not revenue | ||||
| Cash at bank | £1.1m | £373k | £517k | — |
| Net assets | £3.4m | £5.5m | £7.3m | — |
| Fixed assets | £7.9k | £4.6k | £0 | — |
| Current assets | £4.2m | £6m | £7.9m | — |
| Debtors | £773k | £688k | £592k | — |
| Deferred income | £467k | £365k | £480k | — |
| Source | FullAccounts · bulk data Sep 2024 | FullAccounts · bulk data Sep 2024 | FullAccounts · bulk data Jun 2025 | Accounts · bulk data Jun 2026 |
How the business works
- Profit margin
- 53.4%
- Profit ÷ revenue.
- Gross margin
- 58.8%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £180k
- Revenue ÷ average employees.
- Profit per employee
- £96k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- —
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- —
- Now —
- Cash at bank
- —
- Now —
- Headcount
- ▼14%
- Now 18
- Deferred income
- —
- Now —
- Fixed assets
- —
- Now —
Group structure
Ownership chain
- Sovereign Capital Partners LLPultimate parent75–100%
- BB Shelf 4 LLP75–100%
- Bioscript Holdings Limited75–100%
- Bioscript Midco 1 Limited75–100%
- Bioscript Midco 2 Limited75–100%
- Bioscript Limited75–100%
- Azimuth Pharma Limited75–100%
- Fortis Pharma Consulting Limitedthis company
Bands show the share of ownership each company holds in the one below it.
From the Persons with Significant Control register (corporate controllers only).
Similar profitable businesses
- Tepnel Pharma Services LimitedGlasgow · Other professional, scientific and technical activities n.e.c.
- Revenue
- £3.4m
- Profit
- £248k
- Staff
- 30
- Nash Maritime LimitedStockport · Other professional, scientific and technical activities n.e.c.
- Revenue
- £3.4m
- Profit
- £849k
- Staff
- 21
- Society of Petroleum Engineers Europe LimitedWestminster · Other professional, scientific and technical activities n.e.c.
- Revenue
- £3.2m
- Profit
- £1.4m
- Staff
- 21
- Trident Trust Company (U.K.) LimitedLondon · Other professional, scientific and technical activities n.e.c.
- Revenue
- £3.2m
- Profit
- £185k
- Staff
- —
- Collinda LimitedDorking · Other professional, scientific and technical activities n.e.c.
- Revenue
- £3.1m
- Profit
- £166k
- Staff
- 2
- Crossroads Real Estate (Europe) LimitedLondon · Other professional, scientific and technical activities n.e.c.
- Revenue
- £3.9m
- Profit
- £42.5k
- Staff
- 10
Sources
Latest figures from accounts for the year to 30 Sep 2025 (profit £1.7m), from the Companies House accounts bulk data published Jun 2026. Spotted an error? Request a correction.
Updated from Companies House on 13 Oct 2026
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.